BIOMEDICINE
• Sicor and Watson Pharmaceuticals have chosen separate paths
• BioGentech moves to a highly visible space next to the 405 Freeway
BUSINESS SERVICES
• Regulators are looking at the pending sale of Consolidated Reprographics to the owner of OCB Reprographics
COMMENT
• The Times' new take on OC, an Editorial
• Accounting post-Enron
• China is poised to become an economic power
DINING
• A piece of Paris in Dana Point, courtesy of Byron Gemmell
ECONOMY
• Ingram Micro again leads OC companies on the Fortune 500
ENTERTAINMENT
• "Cheval" is a good ride for the audience
FEATURES
• Executive Summary, People
FINANCE
• Merrill Lynch is moving out of Newport Center
• Market Watch
• Special Report: Mergers and Acquisitions—The billion-dollar deal disappeared last year; small deals still are getting done; the OC attorney in the middle of the AmgenImmunex deal; the list of OC deals in the past 12 months
HEALTHCARE
• Masimo says it's locked out of many hospitals
HONORS
• We reprint the Business Journal story that won Chris Cziborr a national writing award
LAW
• Hart, King & Coldren is adding attorneys and looking for a larger space
MARKETING
• Quiksilver starts marketing its golfwear line
REAL ESTATE
• Apartments and office space are planned for Parker Hannifin's former Irvine site
• B. Braun McGaw has excess land in Irvine that it's trying to get entitled for apartments
• Equity Office is sprucing up Experian's soon-to-be vacated Orange digs
• Real Estate Deals
• Signs of recovery bode well for the West County industrial market
• Two luxury apartment projects are under way in Fullerton
TECHNOLOGY
• OC's tech upstarts are looking for more money
• Tech leaders plan their response to a terrorist attack
TRADE
• How Pakistan's situation affects business depends on the company